» Articles » PMID: 26835093

HCN4, Sinus Bradycardia and Atrial Fibrillation

Overview
Date 2016 Feb 3
PMID 26835093
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Based on their established role in the generation of spontaneous activity in pacemaker cells and control of cardiac rate, funny/ hyperpolarisation-activated, cyclic nucleotide gated 4 (HCN4) channels are natural candidates in the search for causes of sinus arrhythmias. Investigation of funny current-related inheritable arrhythmias has led to the identification of several mutations of the HCN4 gene associated with bradycardia and/or more complex arrhythmias. More recently, the search has been extended to include auxiliary proteins such as the minK-related peptide 1 (MiRP1) β-subunit. All mutations described so far are loss-of-function and in agreement with the role of funny channels, the predominant type of arrhythmia found is bradycardia. Funny channel-linked arrhythmias, however, also include atrioventricular (AV) block and atrial fibrillation, in agreement with an emerging new concept according to which defective funny channels have a still unexplored role in impairing AV conduction and triggering atrial fibrillation. Also, importantly, recent work shows that HCN4 mutations can be associated with cardiac structural abnormalities. In this short review I briefly address the current knowledge of funny/HCN4 channel mutations and associated sinus and more complex arrhythmias.

Citing Articles

Exosomal Preconditioning of Human iPSC-Derived Cardiomyocytes Beneficially Alters Cardiac Electrophysiology and Micro RNA Expression.

Rosand O, Wang J, Scrimgeour N, Marwarha G, Hoydal M Int J Mol Sci. 2024; 25(15).

PMID: 39126028 PMC: 11313350. DOI: 10.3390/ijms25158460.


Wide Spectrum of Bradyarrhythmias and Supraventricular Tachyarrhythmias in Sportsmen: Run Forrest, Run?!.

Kampka Z, Drabczyk M, Pilka N, Orszulak M, Rycyk M, Mizia-Stec K Rev Cardiovasc Med. 2024; 25(6):221.

PMID: 39076333 PMC: 11270092. DOI: 10.31083/j.rcm2506221.


Localization of hyperpolarization-activated cyclic nucleotide-gated channels in the vertebrate retinas across species and their physiological roles.

Kim D, Roh H, Lee H, Kim S, Im M Front Neuroanat. 2024; 18:1385932.

PMID: 38562955 PMC: 10982330. DOI: 10.3389/fnana.2024.1385932.


Ivabradine could not decrease mitral regurgitation triggered atrial fibrosis and fibrillation compared with carvedilol.

Lee W, Lin Y, Shih J, Chen Z, Wu N, Chang W ESC Heart Fail. 2023; 11(1):251-260.

PMID: 37963437 PMC: 10804175. DOI: 10.1002/ehf2.14577.


The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data.

Verkerk A, Wilders R Biomedicines. 2023; 11(9).

PMID: 37760888 PMC: 10525944. DOI: 10.3390/biomedicines11092447.


References
1.
Al-Ani M, Munir S, White M, Townend J, Coote J . Changes in R-R variability before and after endurance training measured by power spectral analysis and by the effect of isometric muscle contraction. Eur J Appl Physiol Occup Physiol. 1996; 74(5):397-403. DOI: 10.1007/BF02337719. View

2.
DiFrancesco D, Ducouret P, Robinson R . Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science. 1989; 243(4891):669-71. DOI: 10.1126/science.2916119. View

3.
Verkerk A, Wilders R . Pacemaker activity of the human sinoatrial node: effects of HCN4 mutations on the hyperpolarization-activated current. Europace. 2014; 16(3):384-95. DOI: 10.1093/europace/eut348. View

4.
Decher N, Chen J, Sanguinetti M . Voltage-dependent gating of hyperpolarization-activated, cyclic nucleotide-gated pacemaker channels: molecular coupling between the S4-S5 and C-linkers. J Biol Chem. 2004; 279(14):13859-65. DOI: 10.1074/jbc.M313704200. View

5.
DiFrancesco D, Camm J . Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs. 2004; 64(16):1757-65. DOI: 10.2165/00003495-200464160-00003. View